Neuronal migration is essential for nervous system development in all organisms and is regulated in the nematode, C. elegans, by signaling pathways that are conserved in humans. Here, we demonstrate that the insulin/IGF-1-PI3K signaling pathway modulates the activity of the DAF-16/FOXO transcription factor to regulate the anterior migrations of the hermaphrodite-specific neurons (HSNs) during embryogenesis of C. elegans. When signaling is reduced, DAF-16 is activated and promotes migration; conversely, when signaling is enhanced, DAF-16 is inactivated, and migration is inhibited. We show that DAF-16 acts nonautonomously in the hypodermis to promote HSN migration. Furthermore, we identify PAK-1, a p21-activated kinase, as a downstream mediator of insulin/IGF-1-DAF-16 signaling in the nonautonomous control of HSN migration. Because a FOXO-Pak1 pathway was recently shown to regulate mammalian neuronal polarity, our findings indicate that the roles of FOXO and Pak1 in neuronal migration are most likely conserved from C. elegans to higher organisms.
INTRODUCTION
The process of neuronal migration, when the cell bodies of newly born neurons migrate from their birthplace to their final positions within the nervous system, is a conserved and critical part of proper nervous system development (reviewed in Marín et al., 2010) . When defective, it can lead to several human disorders of cortex development, including lissencephaly or the related disorder double cortex, epilepsy, and severe mental retardation (reviewed in Ross and Walsh, 2001) .
The hermaphrodite-specific neurons (HSNs) of C. elegans are among the farthest migrating cells in the developing embryo and the only cells that undergo posterior-to-anterior long-range migrations at this stage (Sulston et al., 1983) . They are a pair of bilaterally symmetric motor neurons that are born in the tail and migrate to the midbody of the animal during embryogenesis ( Figure 1A ). In the adult hermaphrodite, the HSNs stimulate egg laying by releasing the neurotransmitter serotonin (Desai et al., 1988) . Forward genetic screens have identified many genetic components required for HSN migration (Desai et al., 1988; Manser and Wood, 1990; Forrester and Garriga, 1997) . Some of the genes identified, which include the homeodomain transcription factor egl-5 (Desai et al., 1988) , exhibit HSN migration defects when mutated due to the fact that they normally act cell autonomously to promote HSN cell fate. Of those genes identified to have a role specifically in the migration process, the Wnt signaling components represent the most well-studied pathway implicated in controlling the anteriorly directed HSN migrations, to date (reviewed in Silhankova and Korswagen, 2007) .
The conserved transcription factor DAF-16/FOXO is the bestknown target negatively regulated by insulin/insulin-like growth factor-1 (IGF-1) signaling through a conserved phosphatidylinositol 3-kinase (PI3K)/Akt pathway in C. elegans (Lin et al., 1997 (Lin et al., , 2001 Ogg et al., 1997; Henderson and Johnson, 2001; Lee et al., 2001 ). This negative regulation of FOXO through IGF-1-mediated signal transduction and PI3K/Akt signaling is conserved in mammalian cells, including neurons, and promotes cell survival by inhibiting the proapoptotic function of FOXO (reviewed in Wen et al., 2012) . In C. elegans, the biological function of DAF-16 has been well studied in the context of aging: enhanced DAF-16 activity through the inactivation of the insulin/IGF-1 signaling pathway promotes extended lifespan and increased stress resistance (reviewed in Wolff and Dillin, 2006; Lapierre and Hansen, 2012) . More recently, PI3K-regulated signaling through DAF-16 has been demonstrated to promote neurite outgrowth in the C. elegans AIY interneurons during development (Christensen et al., 2011) , and a role for insulin/ IGF-1 signaling in the progression of neuronal aging, in part, by inhibition of DAF-16 (Pan et al., 2011; Tank et al., 2011) has been reported.
Here, we describe a role for insulin/IGF-1 signaling through DAF-16/FOXO in modulating the migration of HSNs during development. We demonstrate that null mutations in the daf-16 gene as well as inhibition of DAF-16 activity due to a daf-18/ PTEN mutation and activation of PI3K signaling cause an HSN undermigration phenotype, whereas an increase in DAF-16 activity resulting from decreased insulin/IGF-1 signaling leads to HSN overmigration. Surprisingly, our data indicate that DAF-16 promotes HSN migration cell nonautonomously from the hypodermal tissue. We also implicate pak-1, which encodes a p21-activated kinase, as a downstream effector of DAF-16 activity in the hypodermis during HSN migration.
RESULTS

C. elegans DAF-16/FOXO Regulates the Migration of the HSNs
While studying the biological roles of the endogenous RNAi factors, we discovered a synergy between the RNAi pathway and daf-16 in the regulation of egg laying (L.M.K. and A.G., unpublished data). This prompted us to look for possible HSN defects in daf-16 mutant animals. We found that daf-16(mu86) and daf-16(mgDf50) null mutants displayed HSN undermigration defects ( Figures 1B-1D ). We used a tryptophan hydroxylase GFP reporter (tph-1::gfp) for identifying HSNs and their migration defects. TPH-1 is required for serotonin biosynthesis and is expressed in all serotonergic neurons (Rand and Nonet, 1997) . However, because tph-1 is expressed late in development and allows HSN identification only in late L4 and adult animals, we used an additional reporter, kal-1::gfp, which is expressed in the HSN during both larval and adult stages (Bü low et al., 2002) , to confirm that the daf-16 (null) HSN undermigration phenotype was also present in newly hatched L1 larvae (Figures and daf-16(mu86) mutant animals (C). HSN is visualized with a tryptophan hydroxylase GFP reporter (tph-1::gfp). Images are oriented with the posterior of the animal to the right. Asterisks indicate the vulva, and arrowheads denote the position of properly migrated HSN(s). The arrow in (C) illustrates an HSN that has failed to migrate from its birthplace in the tail of the daf-16(mu86) mutant animal. (D) Quantification of the percentage of animals with an undermigrated HSN from a minimum of two pooled independent experiments per strain in control tph-1::gfp (n = 165), daf-16(mu86) (n = 160), and daf-16(mgDf50) (n = 155) mutants. (E) Quantification of the percentage of animals with an undermigrated HSN in wild-type (n = 50), daf-16(mgDf50); daf-2(e1370) mutant animals (n = 150), and mutant animals containing the pdaf-16d/f::daf-16d/f (n = 168), pdaf-16a::daf-16a (n = 170), or pdaf-16b::daf-16b (n = 179) array. Note that rescue was observed in animals carrying the pdaf-16::daf-16a or pdaf-16::daf-16b arrays. HSNs were visualized by antiserotonin staining. The stacked bars show information about the position of all HSNs in the affected worms (see the description below). Worm schematic legend: stacked bars represent the proportion of HSNs at different positions along the A-P body axis within only those animals containing at least one undermigrated HSN. Thus, because there are two HSNs within each animal and not every HSN is affected, one colored region (light pink) represents the wild-type HSN that remains unaffected in animals containing a second undermigrated HSN, which is represented by the red, green, or blue region. ***p < 0.001 (z test). Error bars represent SE of the proportion (SEP) for the entire stacked column. N.S., not significant. Scale bars, 20 mm. See also Figures S1 and S2. S1A-S1C). These results indicate that DAF-16 is required for proper HSN migration during development rather than having a role in adult neuronal maintenance.
Furthermore, we stained wild-type worms and daf-16 mutant worms with an antiserotonin antibody (Garriga et al., 1993) to exclude the possibility that the transgenes used to visualize the HSNs were possibly enhancing or causing the daf-16 mutant undermigration phenotype. The extent of HSN undermigration was similar in stained and transgenic worms, indicating that all defects seen with the reporters were due to the relevant mutant backgrounds and not to the reporters themselves ( Figures S1D-S1F ). In addition, these results suggest that DAF-16 specifically affects the process of HSN migration rather than HSN identity because undermigrated HSNs still express the neurotransmitter serotonin, a late step in HSN maturation (Desai et al., 1988) .
There are three functionally characterized DAF-16 isoforms: DAF-16a, DAF-16b, and DAF-16d/f (Ogg et al., 1997; Lee et al., 2001; Lin et al., 2001; Kwon et al., 2010) . DAF-16a and DAF-16b proteins are expressed during embryogenesis (Ogg et al., 1997; Henderson and Johnson, 2001; Lee et al., 2001) , and all three isoforms show neuronal expression in developing larvae (Ogg et al., 1997; Henderson and Johnson, 2001; Lee et al., 2001; Kwon et al., 2010) . Therefore, DAF-16 may function in multiple aspects of neuronal development. We determined which DAF-16 isoforms are involved in the regulation of HSN migration by performing antiserotonin staining using daf-2(e1370ts); daf-16(mgDf50) mutant worms or isogenic strains expressing isoform-specific DAF-16 proteins under the control of the corresponding daf-16 promoters (Kwon et al., 2010) grown at 20 C. We found that isoforms DAF-16a and DAF-16b, but not the DAF-16d/f isoform, rescued the undermigration defect of the daf-16 mutant ( Figure 1E ); in contrast, DAF-16d/f has been shown to contribute most significantly to the regulation of lifespan (Kwon et al., 2010) . Mutation of daf-2 leads to enhanced DAF-16 activity and therefore may facilitate the rescue of daf-16(mgDf50) by the transgenic arrays. Therefore, we have confirmed that daf-2(e1370ts) mutants lack HSN migration defects when grown at the permissive temperatures of 15 C or 20 C (data not shown). Moreover, to confirm that the daf-2(e1370ts) allele was not contributing to the rescue observed in Figure 1E , we also show that the DAF-16a and DAF-16b isoforms can rescue the HSN undermigration defects in the daf-16 mutant to a similar extent in the wild-type and daf-2(e1370ts) backgrounds (compare Figures 1E and S1G ). This is consistent with daf-2(e1370) being a temperature-sensitive allele (Vowels and Thomas, 1992; Kimura et al., 1997) . Combined, these results suggest that two isoforms of DAF-16 (a and b) may regulate the transcription of genes required to promote HSN migration during development. Consistently, the DAF-16b isoform was recently shown to control neurite outgrowth in C. elegans (Christensen et al., 2011) , and a role for DAF-16a in regulating neuronal aging has been reported (Pan et al., 2011; Tank et al., 2011) DAF-16 Interacts with Other Known Pathways Regulating HSN Migration Many genes have been implicated in the process of HSN migration (Desai et al., 1988) . Of those genes shown to affect the process of HSN migration, rather than HSN identity, the Wnt and Frizzled families of genes are best studied (reviewed in Silhankova and Korswagen, 2007) . Specifically, the EGL-20 Wnt ligand and other posteriorly expressed Wnts function as repellents to direct the HSNs anteriorly and are believed to act directly on the HSN because the Wnt receptor MIG-1/Fz was shown to act cell autonomously in the HSNs (Pan et al., 2006) . We show that the HSN undermigration defect in a daf-16 null mutant is enhanced by an egl-20 null mutation (Coudreuse et al., 2006) (Figure S2A ), which suggests that daf-16 and egl-20 act in parallel pathways. However, because of the redundancy between Wnt ligands, this result allows us only to rule out the possibility that DAF-16 is exclusively acting through EGL-20 to influence HSN migration. It is still possible that DAF-16 functions in the same genetic pathway with the Wnts to control HSN migration, for example, by regulating Wnt expression and/or function.
C. elegans contains one syndecan gene, sdn-1, which encodes a transmembrane heparan sulfate proteoglycan (HSPG) and has been shown to act in the nervous system to promote HSN migration (Rhiner et al., 2005) . Interestingly, the absence of mammalian syndecan-4 leads to decreased Akt activation and reduced FOXO phosphorylation (Partovian et al., 2008) . Also, mammalian syndecan-1 can suppress the insulin signaling components phosphoinositide-dependent protein kinase 1 (PDK-1) and Akt to induce apoptosis in human prostate cancer cells (Hu et al., 2010) . In light of the mammalian syndecan family interaction with insulin/IGF-1 signaling components, we investigated the C. elegans sdn-1 interaction with daf-16. We observed an enhancement in HSN undermigration in a strain with null mutations of these two genes compared to either single mutant alone ( Figure S2B ), placing daf-16 and sdn-1 in parallel genetic pathways.
The PI3K Signaling Pathway Regulates DAF-16 Activity to Control HSN Migration DAF-18, the phosphatase and tensin homolog (PTEN) in C. elegans, acts in the insulin/IGF-1 signaling pathway to promote DAF-16 activity by dephosphorylating AGE-1 PI3 kinase-generated PIP3 and inhibiting PI3K signaling (Ogg and Ruvkun, 1998; Solari et al., 2005) (Figure 2A ). Therefore, a loss of function of PTEN leads to inhibition of DAF-16 by activated PI3K signaling. We observed undermigration of the HSN in the daf-18 (PTEN) null mutant background, consistent with reduced DAF-16 activity ( Figures 2B-2D ). The penetrance of HSN undermigration in daf-18(ok480) was similar to that in daf-16(mu86); moreover, a combination of daf-16(mu86); daf-18(ok480) null alleles did not enhance the HSN undermigration phenotype of either single mutant ( Figure 2D ), indicating that daf-16 and daf-18 act in the same pathway to control neuronal migration. Furthermore, we found that a transgenic array expressing DAF-18 under the control of its endogenous promoter rescued the HSN undermigration phenotype of the daf-18(mg198) null mutant ( Figure 2E ). Together, these observations suggest that the PI3K signaling pathway works upstream of DAF-16 to control its activity required for promoting HSN migration.
PI3K Signaling and DAF-16 Act Nonautonomously in HSN Migration
To determine which tissue DAF-16/FOXO activity is required in for promoting the anterior HSN migrations, we first utilized published transgenic strains where a daf-18 cDNA is expressed under various tissue-specific promoters in a daf-2; daf-18 mutant background . We began with daf-18 rescue for two reasons: first, there is only one DAF-18 isoform compared to the two DAF-16 isoforms that rescue HSN migration ( Figures 1E and 2E) ; and second, because the daf-18 undermigration phenotype arises due to a decrease in DAF-16 activity ( Figure 2D ), rescuing the daf-18 mutant is the equivalent of restoring DAF-16 function. We performed antiserotonin staining using daf-2(e1370); daf-18(mg198) mutant worms or isogenic strains expressing daf-18 cDNA under the control of various tissue-specific promoters ( Figure S3A ) and determined that daf-18 cDNA driven by the pan-neuronal unc-119 promoter rescued the daf-18 mutant. However, given that this promoter (A) DAF-18 acts in the insulin/IGF-1 signaling pathway to promote DAF-16 activity by inhibiting PI3K signaling. When pathway components in red are active, DAF-16 is phosphorylated and inactive due to its retention in the cytoplasm. When pathway components in green are active, DAF-16 is no longer phosphorylated and can translocate into the nucleus to regulate its target genes. (B and C) DIC images of adult hermaphrodites (top) and corresponding epifluorescent images of the HSNs (bottom) in wild-type (B) and daf-18(ok480) mutant animals (C). HSN is visualized with a GTP cyclohydrolase GFP reporter (cat-4::gfp), which is expressed in all dopaminergic and serotonergic neurons (Flames and Hobert, 2009) . Images are oriented with the posterior of the animals to the right. Asterisks indicate the vulva, and arrowheads denote the position of properly migrated HSN(s). The arrow in (C) illustrates an HSN that has failed to migrate the full distance and terminates near the PDE neuron, which is also marked by an arrow in (B) and (C). (D) Quantification of the percentage of animals with an undermigrated HSN from three pooled independent experiments per strain in tph-1::gfp (n = 165) and cat-4::gfp (n = 213) controls, daf-16(mu86) (n = 160), daf-18(ok480) (n = 211), and daf-16(mu86); daf-18(ok480) (n = 112) mutant animals. Note that the cat-4::gfp reporter was used to visualize the HSNs in the daf-18 single-and double-mutant backgrounds. There is no significant difference among the daf-16 and daf-18 single and double mutants (z test). (E) Quantification of the percentage of animals with an undermigrated HSN from two pooled independent experiments in daf-18(mg198) mutant animals (n = 95) and mutant animals containing the Ex pdaf-18::daf-18 (n = 98) rescuing transgenic array. The daf-18(mg198) mutants that had the rescuing transgenic array (+) or their siblings that had lost the array (À) were scored. See Figure 1 for detailed description of worm schematic legend. ***p < 0.001 (z test). Error bars represent SEP. Scale bars, 20 mm.
is also active in the embryonic hypodermal tissue (Hardin et al., 2008) , and because HSN migration occurs during embryogenesis, the rescue observed from this promoter could have resulted from DAF-18 expression in neuronal tissue, hypodermal tissue, or both.
To narrow down these possibilities, we generated transgenic animals that used the unc-119 promoter (Maduro et al., 2000) or the hypodermal dpy-7 promoter (Gilleard et al., 1997) to drive expression of a daf-18 cDNA. Expression of DAF-18 under the control of both these promoters rescued the HSN migration defects in daf-18 mutants ( Figure 3A) , suggesting that hypodermal expression of DAF-18 is sufficient for rescue. Next, we crossed the two transgenic lines to each other to create animals that simultaneously expressed DAF-18 under both the unc-119 promoter and the dpy-7 promoter because we reasoned that if DAF-18 is required in the neuronal tissue as well as the hypodermal tissue, then a more complete rescue would be observed in animals expressing DAF-18 from both promoters as compared to either single promoter alone. We determined that rescue of the HSN migration defects in daf-18 mutants was not enhanced in animals expressing DAF-18 from the two promoters ( Figure 3B ), suggesting that DAF-18 acts predominately in the hypodermal tissue to control HSN migration.
Consistently, we found that a second pan-neuronal promoter, rab-3, which is active during embryogenesis and is not expressed in the hypodermis (N. Stefanakis, I. Carrera, and O. Hobert, personal communication), does not rescue the daf-18 null phenotype when used to express a full-length daf-18 cDNA ( Figure S3B ). Moreover, we find that daf-18 cDNA driven from the unc-86 promoter, which is expressed in a subset of neurons including the HSN (Baumeister et al., 1996) , does not rescue the daf-18 null mutant ( Figure S4A ). Notably, this same promoter has been used previously to rescue the HSN undermigration defects present in mig-1/Fz mutants (Pan et al., 2006) . Furthermore, in agreement with our observations that DAF-18 does not work cell autonomously to regulate HSN migration, we find that the cDNA of daf-16b fused to TagRFP driven by the unc-86 promoter fails to rescue the HSN undermigration defects seen in the daf-16 null mutant ( Figures S4B and S4C ).
Next, we tested whether or not hypodermal expression of DAF-16 could rescue the HSN migration defects in daf-16 mutants. To do this, we generated transgenic animals that used the hypodermal dpy-7 promoter to drive expression of the daf-16b cDNA fused to TagRFP because this isoform rescued the daf-16 mutant most significantly ( Figure 1E ). Expression of DAF-16b::TagRFP in the hypodermis rescued the HSN migration defects of daf-16 mutants ( Figure 3C ). We observed that plasmid constructs with the dpy-7 or unc-119 promoters expressing either DAF-18 or DAF-16b did not rescue the daf-18 or daf-16 mutant phenotypes to the same extent as the constructs with their endogenous promoters. This likely reflects the fact that expression of DAF-16 in the hypodermis is toxic to the worm, as has been previously reported by Libina et al. (2003) . Also, we found worms expressing the pdpy-7::daf-18 transgenic array to be slow growing and sick, with many dead larvae produced. Thus, it is likely that we selected for transgenic lines expressing low levels of both DAF-18 and DAF-16 in the hypodermal tissue.
Importantly, and consistent with the rescue by DAF-18 and DAF-16 expressed in the hypodermis, we found that DAF16b::TagRFP was localized in the nuclei of hypodermal cells during the 1.5-fold stage of embryogenesis ( Figure 3D , top panels) when HSN migration takes place (Sulston et al., 1983; Pan et al., 2006) , but not during the L1 stage when HSN migration is complete ( Figure 3D , bottom panels). This result demonstrates that DAF-16b nuclear translocation is actively regulated in the hypodermal tissue during embryonic development. Taken together, our results indicate that DAF-16 activity is required in the embryonic hypodermal tissue to nonautonomously promote the migration of the HSNs.
Enhanced DAF-16 Activity Leads to HSN Overmigration DAF-16 in C. elegans is negatively regulated by insulin/IGF-1 signaling, in part through excluding its nuclear localization (Henderson and Johnson, 2001; Lee et al., 2001; Lin et al., 2001 ); therefore, DAF-16-dependent transcription is activated in insulin/IGF-1 signaling mutants. Because daf-16 null mutants exhibit an HSN undermigration defect, we investigated whether activation of DAF-16 could cause HSN overmigration, meaning that the HSNs migrate beyond their normal destination flanking the vulva. We tested the age-1(hx546) (PI3K) mutant (Friedman and Johnson, 1988; Tissenbaum and Ruvkun, 1998) for HSN migration defects and found an HSN overmigration phenotype in a small number of adult animals grown at 20 C. Notably, the dramatic extent of HSN overmigration in these few affected animals ( Figure 4A ) was never observed in the wild-type population. Because DAF-16 can be directly activated by the c-Jun N-terminal kinase (JNK) upon heat stress (Oh et al., 2005) , we tested whether or not a combination of heat stress and age-1 loss of function could enhance the overmigration phenotype seen at 20 C by increasing DAF-16 nuclear activity. In order to enhance DAF-16 nuclear activity during embryogenesis specifically, we let age-1(hx546) embryos develop at a higher temperature of 27 C and then shifted the L1 larvae back to 20 C and allowed them to grow to adulthood. We then scored HSN migration defects in these adult animals and found a significant increase in frequency of HSN overmigration compared to wild-type (Figure 4B ). This enhanced overmigration at higher temperature was DAF-16 dependent because it did not take place in daf-16; age-1 double-mutant animals ( Figure 4B ).
HSN overmigration has also been observed in animals with missing or anteriorly displaced canal-associated neurons (CANs) (Forrester and Garriga, 1997) , a pair of bilaterally symmetric neurons that are born in the head and migrate posteriorly to the center of the embryo just anterior to the HSNs ( Figure 4C ) (Sulston et al., 1983) . In order to rule out the possibility that the DAF-16-dependent overmigration we describe could be contributed to by anteriorly displaced CANs in the age-1 mutant background, we examined the position of the CANs in larvae using the kal-1::gfp reporter, which marks the CANs in addition to the HSNs (Bü low et al., 2002). We did not observe a defect in CAN migration in the age-1 mutant at 27 C, and in fact, the HSN even migrated past the CAN in some cases ( Figure 4D ). Together, these observations indicate that HSN overmigration in the age-1 mutant is due strictly to an increase in DAF-16 activity mediated by the loss of PI3K activity and JNK activation during embryogenesis.
Our data predict that DAF-16-dependent overmigration is occurring independently of pathways controlling the posterior migration of the CANs because the CANs migrate normally in age-1 mutants. Therefore, we reasoned that if we disrupted CAN migration in the age-1 mutant background, that HSN overmigration might be enhanced due to the combined effect of age-1 loss of function and CAN displacement. To do this, we combined the age-1 mutant with a null allele of vab-8. vab-8 encodes a kinesin-related protein, which is required for most posterior migrations, including the CANs (Manser and Wood, 1990; Wightman et al., 1996; Wolf et al., 1998) . In the vab-8 mutant background, the CANs fail to migrate out of the head, and the HSNs can migrate past their normal stopping point in 34% of animals ( Figure 4E ). In addition, we also noted that in the vab-8 mutant background, the HSN undermigrated in 32% of animals ( Figure 4E ), suggesting that vab-8 is also partially required for the anterior migrations of the HSNs. Consistent with our observation, this undermigration phenotype has been previously reported by Manser and Wood (1990) . At 20 C in the age-1; vab-8 double mutant, we observed that the positions of the HSNs along the anterior-posterior (A-P) body axis were shifted anteriorly in a DAF-16-dependent manner, such that the age-1 mutant suppressed the vab-8 HSN undermigration phenotype ( Figure 4E ). This result indicates that a loss of PI3K signaling in a vab-8-sensitized mutant background can shift the HSNs anteriorly, even in the absence of JNK signaling. Consistently, we also observed enhanced HSN overmigration in a DAF-16-dependent manner when the age-1; vab-8 double mutant was grown under heat stress at 27 C ( Figure S5 ). Combined, our results demonstrate that DAF-16-dependent HSN overmigration occurs in parallel to pathways controlling the posterior migration of the CANs and that increased DAF-16 activity can shift the HSNs anteriorly along the A-P body axis.
The DAF-2 Insulin/IGF-1 Receptor Acts Upstream of DAF-16 to Control HSN Migration In C. elegans, the insulin/IGF-1 receptor is encoded by a single gene, daf-2 (Kimura et al., 1997), and acts upstream of PI3K signaling to inhibit DAF-16 activity. In order to determine if HSN migration is controlled through DAF-2 receptor signaling, we examined the temperature-sensitive daf-2(e1370) mutant containing a missense mutation in a highly conserved residue of the kinase domain (Kimura et al., 1997) . Embryos were allowed to develop at the restrictive temperature of 27 C before being shifted as L1 larvae to the permissive temperature of 20 C, where they completed their development. Consistent with a release of DAF-16 inhibition and increased DAF-16 activity, daf-2 mutants displayed a DAF-16-dependent HSN overmigration phenotype ( Figures 5A and 5C ). Interestingly, in addition to an overmigration phenotype, daf-2 mutants also exhibited an HSN undermigration phenotype that did not enhance the null daf-16 mutant ( Figures 5B and 5C ). This suggests that the undermigration phenotype in daf-2(e1370) is due to decreased DAF-16 activity. To further confirm this, we performed epistasis analysis using the age-1(hx546) allele, which we have shown to cause a DAF-16-dependent HSN overmigration phenotype. We observed that reducing AGE-1 activity suppressed the daf-2 mutant undermigration phenotype ( Figure 5D ), which is consistent with its dependence on DAF-16. In C. elegans, the insulin-like peptides have been shown to function as either DAF-2 agonists or antagonists (reviewed in Lapierre and Hansen, 2012) . Therefore, misregulation of HSN migration in both directions could be due to an inconsistent control of signaling and downstream DAF-16 activity in the daf-2(e1370) mutant, which is not null. We also observed animals with HSN under-and overmigration defects using another loss-of-function allele, daf-2(m65) (Patel et al., 2008 ) (data not shown). However, the age-1(hx546) non-null loss-of-function allele that we use displays only an overmigration phenotype. Therefore, it is also possible that HSN undermigration seen in daf-2 loss-of-function mutants is due to inappropriate age-1-dependent signaling that occurs when daf-2 function is reduced. The suppression of the undermigration phenotype seen in daf-2(e1370) in daf-2(e1370); age-1(hx546) double-mutant worms is consistent with this possibility.
PAK1 Acts Nonautonomously and Downstream of Insulin/IGF-1-DAF-16 Signaling in HSN Migration
Recently, FOXO transcription factors have been identified as regulators of neuronal polarity in the mammalian brain through their direct activation of the gene pak1, which encodes a p21-activated kinase (de la Torre-Ubieta et al., 2010). To determine whether FOXO-dependent Pak1 regulation is conserved and whether it is relevant to the regulation of HSN migration, we analyzed the orthologous pak-1 in C. elegans. First, we determined that a putative null allele, pak-1(ok448), which removes most of the kinase region (Lucanic et al., 2006) , causes HSN undermigration defects similar to that of the daf-16 null mutant ( Figures 6A and S6A ) and that pak-1(ok448) does not enhance the HSN undermigration phenotype of daf-16 ( Figure 6A ). However, because the daf-16 (null) phenotype displays a stronger expressivity than the pak-1 (null) allele, that is the degree of HSN undermigration is more severe in daf-16 (null) ( Figure 6A ), DAF-16 is likely to have additional downstream effectors. Epistasis analysis using the age-1 loss-of-function mutant further places pak-1 downstream of insulin/IGF-1 signaling. The pak-1 mutant suppressed the HSN overmigration phenotype observed in the age-1 mutant, which we have shown to be DAF-16 dependent ( Figure 6B ). Altogether, these results are consistent with pak-1 acting as a downstream effector of DAF-16 in HSN migration. We examined the expression pattern of pak-1 during embryogenesis using a ppak-1::NLS-TagRFP transcriptional reporter. The HSNs are born in the tail of the comma-stage embryo and begin migrating 10 min later (Sulston et al., 1983) . We determined that pak-1 is expressed in the hypodermal tissue before and during the HSN migrations ( Figure 6C ), consistent with earlier PAK-1 expression pattern reports (Chen et al., 1996; Iino and Yamamoto, 1998 ). Next, we tested whether or not hypodermal expression of PAK-1 could rescue the HSN migration defects in pak-1 mutants. To do this, we expressed pak-1 cDNA fused to TagRFP using the dpy-7 hypodermal promoter. Expression of PAK-1::TagRFP in the hypodermis rescued the HSN migration defects (A) smFISH against pak-1 mRNA in embryos. pak-1 expression is seen in the early embryo and continues throughout all stages of embryogenesis. Expression is highly localized to the hypodermal cells beginning in the bean stage and occurring through the 1.5-fold stage, which is consistent with the timing of HSN migration. We assume that these are hypodermal cells based on the pak-1 transcriptional reporter overlap with marked hypodermal cells ( Figure 6C ). pak-1 expression is dramatically reduced in the 3-fold embryo and becomes restricted mainly to the CAN. Outlined is what we assume to be the CAN based on the high expression of a pak-1 transcriptional reporter in the CAN of a newly hatched L1 ( Figure S6 ) and the position of this cell in the embryo. of pak-1 mutants ( Figure 6D ), placing the focus of PAK-1 activity in the same tissue as that of DAF-16. Hypodermal expression of PAK-1, however, was insufficient to rescue the daf-16 (null) phenotype (data not shown), consistent with the suggestion of our genetic data that DAF-16 likely regulates multiple genes to affect HSN migration, just as it does for lifespan (reviewed in Murphy, 2006) . Consistent with the possibility of direct regulation of pak-1 transcription by DAF-16, we found that pak-1 contains consensus DAF-16 binding site sequences in its promoter (Furuyama et al., 2000; Murphy et al., 2003) , which are conserved among the nematodes ( Figure S6B ). Furthermore, we analyzed a ChIP-seq data set available from the modENCODE project to show that a DAF-16::GFP fusion protein occupies the endogenous pak-1 promoter ( Figure S6C ). In order to test whether DAF-16 regulates pak-1 expression in the hypodermis during HSN migration, we performed single-molecule fluorescence in situ hybridization (smFISH) (Raj et al., 2008) to examine the endogenous pak-1 mRNA expression levels during embryogenesis in wild-type and daf-16(mu86) null embryos. First, consistent with a role in HSN migration, pak-1 transcripts were abundantly expressed prior to and after HSN migration has begun before decreasing in the 3-fold embryo ( Figure 7A ). Second, we observed a small but significant decrease in pak-1 transcripts in the hypodermal cells of comma-stage embryos in the daf-16 null mutant compared to wild-type ( Figure 7B ), but not in the CAN during late embryogenesis ( Figure 7C ), suggesting that DAF-16 specifically regulates pak-1 activity in the embryonic hypodermal tissue. We identify the CANs based on their positions in the developing embryo and the high expression of a pak-1 transcriptional reporter in the CANs of newly hatched L1 larvae ( Figure S7 ). DAF-16 is known to act as a master regulator of transcription in stress response and longevity pathways (reviewed in Murphy, 2006) , and none of its downstream target genes was shown to rescue daf-16 mutant phenotypes when overexpressed. Therefore, it is possible that DAF-16 modulates the expression of a variety of factors, including pak-1, at the transcriptional level in the embryonic hypodermis to promote HSN migration. Embryos stained with an antibody against PAK-1 have revealed its localization to the plasma membrane of hypodermal cells during morphogenesis (Chen et al., 1996) . Thus, DAF-16 may also regulate factors required for PAK-1 activation and/or for its localization to the hypodermal cell boundaries during HSN migration. Overall, our results are consistent with a model wherein nuclear localization of DAF-16 in the embryonic hypodermal cells, specifically at the time of HSN migration, promotes expression of multiple target genes, including pak-1, that are required to control the robustness of the migration process in a cell-nonautonomous manner.
DISCUSSION
In this study, we have uncovered a function of insulin/IGF-1 signaling through DAF-16/FOXO as a regulator of neuronal migration during C. elegans development. We demonstrate that DAF-16 activity is required in the hypodermal tissue to nonautonomously promote the HSN migrations and that this activity relies on the release of insulin/IGF-1-mediated inhibition of DAF-16. We show that a loss of DAF-16 activity leads to an HSN undermigration phenotype and that an increase in DAF-16 activity can cause the HSN to migrate past its normal stopping point. We also identify a nonautonomous role for PAK-1 as a downstream effector of DAF-16 activity in HSN migration. Taken together, our findings describe a genetic mechanism by which the extent of HSN migration can be regulated. Suppression of the insulin/IGF-1 pathway can potentiate HSN migration because DAF-16 inhibition is released, and DAF-16-dependent transcription takes place, and conversely, activation of the insulin/IGF-1 pathway can terminate HSN migration through inhibition of DAF-16-dependent transcription.
The FOXO transcription factors are widely expressed in the developing mammalian brain (Hoekman et al., 2006; de la Torre-Ubieta et al., 2010) and are likely to play important roles during neurodevelopment. However, their specific roles are only just beginning to be elucidated. Recently, the FOXOs were shown to be required cell autonomously for neuronal polarity in the mammalian brain (de la Torre-Ubieta et al., 2010) , and a study in C. elegans and mammalian neurons demonstrated a conserved and cell-autonomous role for DAF-16 and FOXO in the control of axon outgrowth (Christensen et al., 2011) . Here, we identify a nonautonomous role for DAF-16 in neuronal migration and build on growing evidence that FOXO transcription factors play important roles during neurodevelopment.
Previous studies have implicated IGF-1 signaling in mammalian brain development: a loss of IGF-1 causes reduced brain size due to a loss of neural progenitors (Beck et al., 1995) , and overexpression of IGF-1 leads to increased brain size (Carson et al., 1993) . It has been suggested that a major output of IGF-1 signaling in this process is inhibition of FOXO because FOXO3 overexpression also leads to reduced brain size and a decrease in neural progenitors (Schmidt-Strassburger et al., 2012) and, consistently, decreased FOXO activity has been reported to result in larger brain size and increased neural progenitor proliferation (Paik et al., 2009; Renault et al., 2009 ). Furthermore, IGF-1 has also been shown to influence the organization of olfactory bulb layering by promoting neuronal migration in a PI3K-dependent manner (Hurtado-Chong et al., 2009) .
It is well known that the PI3K signaling pathway controls many aspects of nervous system development, including neuronal migration, through multiple downstream effectors (reviewed in van Diepen and Eickholt, 2008) . Interestingly, there still remains a discrepancy as to whether or not PI3K signaling affects neuronal migration in a cell-autonomous or -nonautonomous fashion (Backman et al., 2001; Kwon et al., 2001; Marino et al., 2002; Yue et al., 2005) . Although multiple outputs of PI3K signaling have been implicated in neurodevelopment, to our knowledge, the connection between insulin/IGF-1-PI3K signaling and DAF-16/FOXO in the nonautonomous regulation of neuronal migration has not been described previously.
Pak1, a member of the PAK protein kinase family, was previously identified as a direct target of FOXO in controlling neuronal polarity in the mammalian brain (de la Torre-Ubieta et al., 2010) . Here, we demonstrate that the orthologous PAK-1 in C. elegans also acts downstream of DAF-16/FOXO in HSN migration, suggesting conservation for this regulatory connection in neurodevelopment. Although a role for Pak1 in cell migrations has been previously described in both C. elegans (Lucanic et al., 2006; Peters et al., 2013) and mammals (reviewed in Kreis and Barnier, 2009) , to our knowledge, a nonautonomous role for Pak1 in regulating the process of migration has not been reported. It will be interesting for future studies to determine whether or not FOXO-Pak1 is also nonautonomously required for mammalian neuron migration.
Pak1 has many substrates that control cytoskeletal dynamics (reviewed in Ye and Field, 2012) . It is thought to primarily mediate the migration of cells in a cell-autonomous manner through the activation of LIM kinase, which phosphorylates and inhibits cofilin, an actin-regulatory protein, in order to stimulate actin polymerization and cell movement (reviewed in Ye and Field, 2012) . From the genetic model we describe in this study, we can propose three possible scenarios for how PAK-1 might regulate HSN migration nonautonomously in C. elegans: first, PAK-1 could remodel the actin cytoskeleton and/or regulate cell adhesion at hypodermal cell boundaries to help guide the HSN along its migratory route; second, PAK-1 could regulate the expression of an extracellular molecule that is secreted from the hypodermis to act on the HSN and promote its migration; and third, PAK-1 could be required for repressing inappropriate signaling from the hypodermis to the HSN during migration.
The negative regulation of DAF-16/FOXO by insulin/IGF-1 signaling was initially established in the regulation of longevity and stress response in C. elegans (Lin et al., 1997; Ogg et al., 1997) and was later shown to be conserved in mammals (reviewed in Kops and Burgering, 2000) . Given the conservation of the genetic networks regulating long-range cell migrations (Kee et al., 2007) , it is likely that the control of neuronal migration in vertebrates includes a similar insulin/IGF-1-FOXO branch.
EXPERIMENTAL PROCEDURES
C. elegans Strains
Strains were maintained at 20 C unless otherwise noted, using standard methods as described by Brenner (1974) . Bristol N2 was the wild-type strain used. All other strains used in this study are listed in the Extended Experimental Procedures.
Molecular Biology and Transgenic Lines
Standard molecular biology techniques were used to construct transgenes. Germline transformation was performed by direct injection of various plasmid DNAs into the gonads of adult wild-type animals as described by Mello et al. (1991) . A detailed description is provided in the Extended Experimental Procedures.
Visualization of the HSNs and CANs
The HSNs were detected by staining adult hermaphrodites with rabbit antiserotonin antibody (Sigma-Aldrich) as previously described by Garriga et al. (1993) 
Microscopy and Quantification
Live animals or embryos were mounted on 2% agarose pads and immobilized with 25 mM sodium azide (Sigma-Aldrich). Worms were examined using a Zeiss AxioImager Z1. All phenotypes were scored as percent animals with at least one undermigrated or overmigrated HSN, and results are presented as stacked bar graphs to represent the proportion of HSNs in positions along the A-P body axis in these animals. When one or both HSN cell bodies were located posterior or anterior to the vulva in adult animals, the animal was scored as mutant. In the L1 larvae, when one or both HSN cell bodies were located posterior to the developing gonad, the animal was scored as mutant. Statistical significance was calculated using the z test.
smFISH smFISH was done as previously described by Raj et al. (2008) . The quantification of the number of mRNA molecules per hypodermal cell was estimated by counting the number of molecules in each of three z slices per comma-stage embryo and then dividing by 78, the number of embryonic hypodermal cells (Sulston et al., 1983) . Statistical significance was calculated using the unpaired t test. A detailed description is provided in the Extended Experimental Procedures. ]; kal-1::gfpIV. AGK442: {daf-18(ok480) IV; ]} (Line 1 in this paper), AGK 443: {daf-18(ok480) IV; ]} (Line 2 in this paper), AGK441: {daf-18(ok480) IV; ]} (Line 3 in this paper), ]} (Line 1 in this paper), ]} (Line 2 in this paper), AGK406: {daf-16(mu86) I; ]} (Line 3 in this paper), AGK671: {daf-18(ok480) IV; ]} (Line 1 in this paper), AGK678: {daf-18(ok480) IV; ]} (Line 2 in this paper), AGK680: {daf-18(ok480) IV; ]} (Line 3 in this paper).
SUPPLEMENTAL INFORMATION
Molecular Biology
A daf-18 cDNA was obtained by PCR with N2 cDNA as a template, with the forward primer containing a KpnI site 5 0 -ATTGAAGG TACCATGGTTACTCCTCCTCCAGATGTG-3 0 and the reverse primer containing an AdeI site 5 0 -GCCGGCGCACCTCGTCTTACAAA TAAATAGCTTGATCAAAA-3.' The unc-119 (Maduro et al., 2000) , dpy-7 (Gilleard et al., 1997) and unc-86 (Baumeister et al., 1996) promoters were obtained by PCR with N2 genomic DNA as a template. The unc-119 promoter was amplified with the forward primer containing a SphI site 5 0 -ATGAAGAATGCATGCCTATTCCTAGACGATTATTGGTTCC-3 0 and the reverse primer containing a SalI site 5 0 -CCAATGCATTGGTTGTCGACATATGCTGTTGTAGCTGAAAATTTTGG-3.' The dpy-7 promoter was amplified with the forward primer containing a SphI site 5 0 -GTTATTGCATGCTCCACGATTTCTCGCAACACATCCC-3 0 and the reverse primer containing a SalI site 5 0 -GCGTCGGTCGACAAAGAACAGGGTGTGATAAATGAAT-3.' A 5.1 kb fragment upstream of the unc-86 transcriptional start site was isolated with the forward primer containing an SphI site 5 0 -CGTGACACTGCATGCTTCAAAAACTGTCAACTAACAAGAT À3 0 and the reverse primer containing a SalI site 5 0 -CGGATGCGGTTGTCGACTCATTCAATTTCACTTTTTCATTCG À3.' The rab-3 promoter subcloned into a modified Fire Kit vector pPD95.75 was provided as a generous gift from the Hobert lab. DNA was inserted into a modified Fire Kit vector pPD95.75, in which we replaced the GFP with a TAGRFP sequence using the KpnI/EcoRI sites. Promoter::tagrfp and Promoter::daf-18 cDNA constructs were created. A daf-16b cDNA was obtained by PCR with N2 cDNA as a template with the forward primer containing a XmaI site 5 0 -TAGGAACCCGGGATGAACGACTCAATA-3 0 and the reverse primer containing an AgeI site 5 0 -GTCGCTACCGGTCCCAAATCAAAATGAAT-3. tagrfp was generated by inserting a SphI/SalI dpy-7 fragment and XmaI/AgeI daf-16b cDNA fragment into our modified pPD95. [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] ;tagrfp was generated by inserting a SphI/SalI unc-86 fragment and XmaI/AgeI daf-16b cDNA fragment into our modified pPD96.75 vector. A pak-1 cDNA was obtained by PCR with N2 cDNA as a template with the forward primer containing a XmaI site 5 0 -GGACTACCCGGGAT GAAAGCTTTCTCATCGTA-3 0 and a reverse primer containing a KpnI site 5 0 -AATATAGGTACCCCTGAGTTGCTAGCTTCGGC GATGCT-3.' Pdpy-7::pak-1::tagrfp was generated by inserting a SphI/SalI dpy-7 fragment and XmaI/KpnI pak-1 cDNA fragment into our modified pPD95.75 vector. A 4kb fragment upstream of the pak-1 ATG was isolated from genomic DNA by PCR and cloned into our modified fire vector with the forward primer containing a HindIII site 5 0 -CCGGCCAAGCTTCAATTCGATGCAATCCATT TAAAAG-3 0 and the reverse primer containing a BamHI site 5 0 -ATACGAGGATCCTTTGGCAAGCCTGGAAAATTGAAAC-3.' The same primers were used to insert the 4kb pak-1 promoter into a modified Fire Kit Vector pPD95.75 containing 2x NLS sequences and a gene encoding TagRFP (generously provided by the Greenwald Lab).
Transgenic Lines
For each tissue-specific promoter, the corresponding transgenes encoding daf-18 cDNA and tagrfp were co-injected at 20 ng/ml together with either pRF4 (rol-6) at 100 ng/ml for the punc-119 construct or pPD118.33 (myo-2::gfp) at 2.5 ng/ml for the pdpy-7 construct. The corresponding transgenes encoding daf-18 cDNA and tagrfp were co-injected at 5 ng/ml together with pPD118.33 (myo-2::gfp) at 2.5 ng/ml for the prab-3 construct. The corresponding transgenes encoding daf-18 cDNA and tagrfp were co-injected at 1 ng/ml together with pPD118.33 (myo-2::gfp) at 2.5 ng/ml for the punc-86 construct. Tissue-specific TagRFP expression was confirmed using Nomarski and fluorescence microscopy. We observed the expected TagRFP pattern for all promoters in embryos and adults at 20 C and 16 C. For hypodermal expression of DAF-16b and PAK-1, the corresponding transgenes encoding daf-16b cDNA::tagrfp or pak-1 cDNA::tagrfp were injected at 20 ng/ml together with pPD118.33 (myo-2::gfp) at 2.5 ng/ml. The corresponding transgene encoding daf-16b cDNA::tagrfp was injected at 1 ng/ml together with pPD118.33 (myo-2::gfp) at 2.5 ng/ml for the punc-86 construct. To create the pak-1 transcriptional reporter lines, the corresponding transgenes were injected at 10 ng/ml together with pRF4 (rol-6) at 100 ng/ml. At least there independent transgenic lines have been analyzed for each pak-1 transcriptional reporter to confirm the expression pattern. smFISH Probes were designed by using the Stellaris RNA FISH probe designer and were received, already conjugated and purified, from Biosearch Technologies. The pak-1 probe was conjugated to CAL Fluor Red 590. Quantification of smFISH was performed using ImageJ software (Schneider et al., 2012) and the cell counter plug-in to manually count mRNA molecules. Stacks of images were taken automatically with 0.3 microns between z-slices. -18(mg198); daf-2(e1370) ; Ex rol-6 mutant animals (n = 50) and mutant animals containing the Ex punc-119::daf-18 (n = 76), Ex pges-1::daf-18 (n = 50), Ex pnhr-77::daf-18 (n = 55) or Ex punc-54::daf-18 (n = 51) array. punc-119 drives expression in neurons as well as the embryonic hypodermis. pges-1 drives expression in the intestinal cells. pnhr-77 drives expression in the seam cells and punc-54 drives expression in the body wall muscles. Note that only the punc-119 driven expression of daf-18 rescued the HSN undermigration phenotype. HSNs were visualized by anti-serotonin staining. (B) Expression of DAF-18 driven by the rab-3 pan-neuronal promoter does not rescue the HSN undermigration defect in daf-18(ok480) mutants. The daf-18(ok480) mutants that had the rescuing array (+) or their siblings that had lost the array (-) were scored. Number of animals scored from two pooled independent experiments per line are: Line 1: (-) n = 69 and (+) n = 83; Line 2: (-) n = 97 and (+) n = 100; Line 3: (-) n = 50 and (+) n = 100. See Figure S1 for detailed description of worm schematic legend. ***p < 0.001 (z-test). Error bars represent SEP. 
